TipRanks
Advertisement
Advertisement

REPL Stock Latest News

Short Report: MiniMed short interest strikes another record high
The FlyShort Report: MiniMed short interest strikes another record high
13d ago
SOC
LOVE
Replimune announces Tudriqev now available in U.S. for advanced melanoma
PremiumThe Fly
Replimune announces Tudriqev now available in U.S. for advanced melanoma
22d ago
REPL
Replimune shareholders approve stock expansion and governance items
PremiumCompany Announcements
Replimune shareholders approve stock expansion and governance items
1M ago
8K
REPL
Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
PremiumClass Action
Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
2M ago
REPL
Replimune price target raised to $21 from $20 at JPMorgan
PremiumThe Fly
Replimune price target raised to $21 from $20 at JPMorgan
2M ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
PremiumClass ActionReplimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
2M ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
Premium
Class Action
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
2M ago
REPL
Replimune reports Q1 EPS (72c), consensus (77c)
Premium
The Fly
Replimune reports Q1 EPS (72c), consensus (77c)
2M ago
REPL
Replimune files automatic mixed securities shelf
PremiumThe Fly
Replimune files automatic mixed securities shelf
2M ago
REPL
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
PremiumClass Action
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
2M ago
REPL
Replimune 9.7M share Spot Secondary priced at $12.06
PremiumThe Fly
Replimune 9.7M share Spot Secondary priced at $12.06
2M ago
REPL
Replimune Raises $150 Million in Equity Offering
PremiumCompany Announcements
Replimune Raises $150 Million in Equity Offering
2M ago
8K
REPL
Replimune Wins FDA Accelerated Approval for TUDRIQEV
PremiumCompany AnnouncementsReplimune Wins FDA Accelerated Approval for TUDRIQEV
3M ago
8K
REPL
Replimune price target raised to $20 from $16 at BMO Capital
Premium
The Fly
Replimune price target raised to $20 from $16 at BMO Capital
3M ago
REPL
Wedbush upgrades Replimune to Outperform following FDA decision
Premium
The Fly
Wedbush upgrades Replimune to Outperform following FDA decision
3M ago
REPL
Replimune upgraded to Outperform from Neutral at Wedbush
PremiumThe Fly
Replimune upgraded to Outperform from Neutral at Wedbush
3M ago
REPL
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
PremiumThe Fly
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
3M ago
REPL
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
3M ago
CI
AIP
Replimune upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Replimune upgraded to Outperform from Market Perform at Leerink
3M ago
REPL
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
PremiumMarket NewsThese 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
3M ago
AXTI
REPL
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
Premium
The Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
3M ago
CL
BSX
Why Is Replimune (REPL) Stock Up Today?
Premium
Market News
Why Is Replimune (REPL) Stock Up Today?
3M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >